XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
Research and development $ 10,602 $ 8,791
General and administrative 4,526 3,588
Total operating expenses 15,128 12,379
Loss from operations (15,128) (12,379)
Other income:    
Other income 38 493
Net loss (15,090) (11,886)
Net unrealized gain on short-term marketable securities 1 51
Comprehensive loss $ (15,089) $ (11,835)
Net loss per common share, basic and diluted $ (0.43) $ (0.42)
Weighted-average number of shares used in computing net loss per common share, basic and diluted 34,744,275 28,499,475